Ligand Royalty Agreement definition

Ligand Royalty Agreement means that certain Royalty Agreement, dated as of the Original Closing Date, by and among Aziyo Med and Ligand, pursuant to which Ligand has the right to receive certain payments from Aziyo Med on the terms and conditions set forth therein as amended, supplemented or otherwise modified from time to time on or prior to the Original Closing Date or following the Original Closing Date in accordance with the terms of the Financing Documents.
Sample 1Sample 2Sample 3
Ligand Royalty Agreement means that certain Royalty Agreement, dated as of May 31, 2017, by and between Aziyo Elutia Med, LLC, a Delaware limited liability company and Ligand Pharmaceuticals Incorporated, a Delaware corporation, as amended, restated, supplemented or otherwise modified from time to time in accordance with the Intercreditor Agreement, and any related documents executed in connection therewith, including but not limited to the guaranty agreement by and between Borrower and Ligand Pharmaceuticals Incorporated.
Sample 1
Ligand Royalty Agreement. The following definition is hereby added to Article I of the Purchase Agreement:
Sample 1

Examples of Ligand Royalty Agreement in a sentence

  • Once per calendar week, Aziyo Med shall cause all amounts on deposit in the Aziyo Med Controlled Account required to be transferred by the Ligand Royalty Agreement, and permitted to be so transferred pursuant to the terms of the Ligand Intercreditor Agreement, to be transferred to the Permitted Ligand Account in order to pay the Ligand Royalty Payments in accordance with the terms of the Ligand Intercreditor Agreement.

  • Any “Event of Default” (or such similar defined term) shall occur under the terms applicable to (a) any Debt of any Loan Party (excluding the Obligations) in an aggregate principal amount (for all such Debt so affected and including undrawn committed or available amounts and amounts owing to all creditors under any combined or syndicated credit arrangement) exceeding $500,000, (b) the Approved AR Loan Facility, or (c) the Ligand Royalty Agreement.

  • Borrowers shall use the proceeds of Loans solely for (a) transaction fees incurred in connection with the Financing Documents and the payment in full on the Closing Date of certain existing Debt of Borrower, (b) to make the “Acquiror Buydown Payments” (as defined in the Ligand Royalty Agreement), and (c) for working capital needs of Borrowers and their Subsidiaries.


More Definitions of Ligand Royalty Agreement

Ligand Royalty Agreement means that certain Development Funding and Royalties Agreement, dated as of May 4, 2019 (as amended from time to time), to which Buyer and Novan are each a party.”
Sample 1

Related to Ligand Royalty Agreement

  • Royalty Agreement means the amended royalty agreement between the Partnership, Vermilion, 1209963 Alberta Ltd. and the Trust dated January 22, 2003 providing for the creation of the Royalty;

  • Sublicense Agreement means any agreement or arrangement pursuant to which Licensee (or an Affiliate or Sublicensee) grants to any third party any of the license rights granted to the Licensee under the Agreement.

  • License Agreement means the agreement between SAP (or an SAP SE Affiliate, or an authorized reseller) under which Customer procured the rights to use SAP Software or a Cloud Service.

  • Technology License Agreement means the agreement in the form of Exhibit H hereto.

  • Cross License Agreement means that certain Cross License Agreement between and among Medarex, Cell Genesys, Inc., Abgenix, Inc., Xenotech, L.P. and Japan Tobacco Inc., dated March 26, 1997.

  • Supply Agreement has the meaning set forth in Section 7.1.

  • CREFC® Intellectual Property Royalty License Fee With respect to each Mortgage Loan (including any REO Mortgage Loan) and for any Distribution Date, the amount accrued during the related Interest Accrual Period at the CREFC® Intellectual Property Royalty License Fee Rate on, in the case of the initial Distribution Date, the Cut-Off Date Balance of such Mortgage Loan and, in the case of any subsequent Distribution Date, the Stated Principal Balance of such Mortgage Loan as of the close of business on the Distribution Date in the related Interest Accrual Period; provided that such amounts shall be computed for the same period and on the same interest accrual basis respecting which any related interest payment due or deemed due on the related Mortgage Loan is computed and shall be prorated for partial periods. For the avoidance of doubt, the CREFC® Intellectual Property Royalty License Fee shall be payable from the Lower-Tier REMIC.

  • Clinical Supply Agreement has the meaning set forth in Section 4.2.

  • End User License Agreement means a license grant or end user license agreement governing software as further described in this Agreement or any applicable Appendix.

  • Commercial Supply Agreement has the meaning set forth in Section 5.2.

  • Development Agreement has the meaning set forth in the Recitals.

  • Collaboration Agreement has the meaning set forth in the Recitals.

  • Third Party Royalties means royalties or payments actually paid by the Company or its Affiliates to an unaffiliated third party for the right to use or exploit technology, products or proprietary rights of such third party to create or sell Licensed Product/s, which third party’s rights would otherwise be infringed or violated.

  • License Agreements shall have the meaning set forth in Section 8.11 hereof.

  • Licensing Agreement means a commercial agreement between a design approval holder and a production approval holder (or applicant) formalizing the rights and duties of both parties to use the design data for the purpose of manufacturing the product or article.

  • Patent License Agreement means the Patent License Agreement substantially in the form of Exhibit C.

  • Software License Agreement means the Motorola Software License Agreement (Exhibit A).

  • Sublicense Fees shall have the meaning set forth in Section 7.3 below.

  • Manufacturing and Supply Agreement means the Manufacturing and Supply Agreement by and between Biogen and Bioverativ, in the form attached hereto as Exhibit C.

  • IP License Agreement shall have the meaning set forth in Section 1.2.

  • Patent Assignment Agreement means the Patent Assignment Agreement attached hereto as Exhibit G.

  • Intercompany License Agreement means any cost sharing agreement, commission or royalty agreement, license or sublicense agreement, distribution agreement, services agreement, intellectual property rights transfer agreement, any related agreements or similar agreements, in each case where all parties to such agreement are one or more of the Company or a Restricted Subsidiary.

  • Manufacturing Agreement has the meaning set forth in Section 4.3.

  • Royalty Payments has the meaning set forth in Section 7.3.1.

  • Overriding Royalty Interest means an interest in the oil and gas produced pursuant to a specified oil and gas lease or leases, or the proceeds from the sale thereof, carved out of the working interest, to be received free and clear of all costs of development, operation, or maintenance.

  • Royalty Report has the meaning set forth in Section 6.3(a).